TiMELiNES
Everything has a timeline
TiMELiNES
2022
FDA approves Rebyota
Rebyota became the first FDA-approved fecal microbiota product for preventing recurrent C. difficile infection.
Context
Appears In
Authority
Sources
Taxonomy
Everything has a timeline
2022
Rebyota became the first FDA-approved fecal microbiota product for preventing recurrent C. difficile infection.
Context
Authority
Taxonomy